Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $43.0550 (1.38%) ($43.0550 - $43.0550) on Tue. Aug. 29, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2% (three month average) | RSI | 54 | Latest Price | $43.0550(1.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.1% a day on average for past five trading days. | Weekly Trend | HALO declines -1.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) XBI(47%) XME(39%) BLOK(36%) XLF(36%) IWO(34%) | Factors Impacting HALO price | HALO will decline at least -1% in a week (0% probabilities). INDA(-39%) VXX(-25%) TBT(-21%) OIH(-16%) VIXM(-13%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1% (StdDev 2%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $42.46(1.4%) | 10 Day Moving Average | $42.67(0.9%) | 20 Day Moving Average | $42.88(0.41%) | To recent high | -2.2% | To recent low | 32.8% | Market Cap | $5.884b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |